4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
Earnings for 4D Molecular Therapeutics (FDMT)
Earnings in 2023 (TTM): -$0.12 B
According to 4D Molecular Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.12 B. In 2022 the company made an earning of -$0.12 B a decrease over its 2021 earnings that were of -$71.34 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for 4D Molecular Therapeutics from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.12 B | 2.58% |
| 2022 | -$0.12 B | 54.25% |
| 2021 | -$71.34 M | 25.89% |
| 2020 | -$56.67 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -1.85% | 🇺🇸 USA |